Maryann Selfe — Investment Strategist & Author

For more than twenty years, I worked across private banking, wealth and asset management, advising family offices, private clients and institutional investors on capital allocation, manager selection, portfolio construction and investment risk.

Across London, Zurich and New York, I held investment advisory responsibility across more than CHF 5 billion in mandates and directly managed over CHF 700 million in client assets.

Over time, I began to see a persistent disconnect.

Women's health represented substantial clinical need and growing commercial opportunity, but institutional investors had limited ways to evaluate the market, access specialist expertise or construct diversified exposure.

The problem was not simply a shortage of capital. It was a shortage of investment infrastructure.

Today, I am the Founder and Chief Investment Officer of Calabar Capital, an institutional investment platform focused on Women's Health and Healthcare AI. I am also the author of The Billion Dollar Blindspot and the Founder and President of FemmeHealth Alliance.

These platforms have distinct roles but share one objective: connecting long-term capital with women's-health opportunities.

My conviction is simple: scientific innovation and unmet need do not automatically create investable markets. Specialist expertise, credible evidence, appropriate investment structures and disciplined capital allocation must evolve alongside them.

That is the institutional investment perspective I bring to my work, writing and speaking.